. . . . . . . . "Mimics constitutively phosphorylated form and has the ability to interact with CD2AP and CIN85/SH3KBP1 without EGF treatment." . "164"^^ . . "164"^^ . . . . . . "Abolishes interaction with CD2AP and CIN85/SH3KBP1." . "164"^^ . . "164"^^ . . "Mutagenesis site occurs in NX_Q96EY5-2 at amino acids 164 - 164." . . . . . . "neXtProt gold" . . . . . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "1" . . . . .